Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)

National Institutes of Health

Published: May 4, 2026

Updated: Jun 21, 2026

Source: grants_gov

About This Opportunity

Grant tender: Bioengineering Research Grants (BRG) (R01. From National Institutes of Health in United States, healthcare. Submission deadline Jul 2029.

This is a grants contract in the health and medical services and Research sectors. Located in United States, North America, this opportunity is open to firms and consortiums, with an estimated budget of USD 500,000. Proposals must be submitted before July 5, 2029.

Published through Grants.gov, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for grants in the health and medical services sector. Grant applications generally require a detailed project proposal, a clear results framework, and evidence of the applicant's capacity to deliver the proposed activities. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This Notice of Funding Opportunity (NOFO) encourages collaborations between the life and physical sciences that: 1) apply a multidisciplinary bioengineering approach to the solution of a biomedical problem; and 2) integrate, optimize, validate, translate or otherwise accelerate the adoption of promising tools, methods, and techniques for a specific research or clinical problem in basic, translational, or clinical science and practice. An application may propose design-directed, developmental, discovery-driven, or hypothesis-driven research and is appropriate for small teams applying an integrative approach to increase our understanding of and solve problems in biological, clinical, or translational science. This NOFO will support clinical trials that test functionality or validate performance in the chosen setting. This NOFO is not intended to support conventional clinical trials that lack translation as the primary motivation. Applications that propose phase III clinical trials in any area of research are not sought by and will not be supported through this NOFO. This NOFO does not support commercial production.

Agency: National Institutes of Health

CFDA: 93.399, 93.395, 93.865, 93.867, 93.393, 93.394, 93.396

Eligible Applicants: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Applicant Types: City or township governments; County governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Independent school districts; Native American tribal organizations (other than Federally recognized tribal governments); Public housing authorities/Indian housing authorities; For profit organizations other than small businesses; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Small businesses; Public and State controlled institutions of higher education; Native American tribal governments (Federally recognized); State governments; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification)

Cost Sharing: No

Contact: National Institutes of Health

Email: bioengineeringresearchgrants@mail.nih.gov

Data provenance

This notice is sourced from Grants.gov and was originally published on May 4, 2026. Last refreshed 3 days ago. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About National Institutes of Health

National Institutes of Health has issued 79 procurement notices on BidsFactory, including 77 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, Research & Innovation, and Information & Communication Technology. All notices are published for United States. Notices are distributed via Grants.gov. Most recent publication: June 16, 2026.

Frequently asked questions about this tender

Where will the contract be performed?

The contract is for delivery in United States. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Grants.gov to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is July 5, 2029. You have 1107 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by National Institutes of Health in United States. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Grants contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is Up to $500,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.